Description
Le-show medical practice management system from Le-yan has a SQL Injection vulnerability, allowing unauthenticated remote attackers to inject arbitrary SQL commands to read, modify, and delete database contents.
Published: 2025-05-02
Score: 9.8 Critical
EPSS: < 1% Very Low
KEV: No
Impact: n/a
Action: n/a
AI Analysis

Analysis and contextual insights are available on OpenCVE Cloud.

Remediation

Vendor Solution

Update to version V3.0.30 or later

Tracking

Sign in to view the affected projects.

Advisories
Source ID Title
EUVD EUVD EUVD-2025-13292 Le-show medical practice management system from Le-yan has a SQL Injection vulnerability, allowing unauthenticated remote attackers to inject arbitrary SQL commands to read, modify, and delete database contents.
History

Wed, 07 May 2025 17:15:00 +0000

Type Values Removed Values Added
First Time appeared Le-show
Le-show le-yan
CPEs cpe:2.3:a:le-show:le-yan:*:*:*:*:*:*:*:*
Vendors & Products Le-show
Le-show le-yan

Fri, 02 May 2025 17:15:00 +0000

Type Values Removed Values Added
Metrics ssvc

{'options': {'Automatable': 'yes', 'Exploitation': 'none', 'Technical Impact': 'total'}, 'version': '2.0.3'}


Fri, 02 May 2025 03:30:00 +0000

Type Values Removed Values Added
Description Le-show medical practice management system from Le-yan has a SQL Injection vulnerability, allowing unauthenticated remote attackers to inject arbitrary SQL commands to read, modify, and delete database contents.
Title Le-show Medical Practice Management System - SQL Injection
Weaknesses CWE-89
References
Metrics cvssV3_1

{'score': 9.8, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H'}


cve-icon MITRE

Status: PUBLISHED

Assigner: twcert

Published:

Updated: 2025-05-02T16:24:42.504Z

Reserved: 2025-04-16T07:44:38.322Z

Link: CVE-2025-3708

cve-icon Vulnrichment

Updated: 2025-05-02T16:24:36.729Z

cve-icon NVD

Status : Analyzed

Published: 2025-05-02T04:15:55.507

Modified: 2025-05-07T16:50:44.930

Link: CVE-2025-3708

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses